Professional Documents
Culture Documents
Verified
Digitally signed by
VARVARA ZACHARAKI
Date: 2015.12.23 12:17:01
EET
Reason: Signed PDF
(embedded)
Location: Athens, Ethniko
Typografio
33225
. 2816
22 2015
. 3/.98494
.
:
1. 54 1 .
. 4262/2014 ( 114),
.
2. . 3918/2011 ( 31/)
,
.
3. .. 63/2005, 90 ( 98/
)
.
4. .. 73/2015 ( 116/)
, ,
.
5. .. 106/2014 ( 173/)
, .
6. . 9/. 70521/1482014 ( 2243/
/1882014) :
,
.
7. . 3/.62448/1382015
:
.....
,
, .
33226
( )
110000092
-
7.(
110000107
110000110
110000120
110000133
130000038
15%)
4,79
130000048
$/3
-&3.
ygt
130000050
)H
130000059
(SGPT-SGOT)
&/
(BIL)
130000047
130000072
130000088
130000090
130000092
130000094
130000095
( )
130000096
130000100
130000104
130000106
130000142
130000152
130000153
130000160
130000188
130000270
150000043
150000045
150000056
120000087
120000204
120000219
120000220
120000230
120000235
(CR)
1D.
3
+E$&
+'/CHOLESTEROL)
/'/CHOLESTEROL)
/'+
CRP
(HBsAg)
5$67
&$
CA 19-
36$
&$
10,96
33227
33228
( )
15-
120000402
120000416
160000016
160000017
160000020
160000024
160000025
160000026
160000027
160000034
160000042
160000045
160000055
160000085
480000063
40000003
40000004
(TGAB)
76+
TSH (ANTI-76+
(TSI $EV
76+
(TSI), TSH receptor
DXWR$E76,$%6
76+
75+75+
WHVW76+
)6+
75+WHVW)6+
58
(T3)
(FT3)
(FT4)
(TESTO)
37+
intact)
PRL
(E2)
(TG)
&2- RIA
33229
( )
'3
11000001
1
11000001
2
11000001
4
7HVW
11000001
9
11000003
0
11000003
1
11000003
2
11000003
7
11000003
8
11000003
9
11000004
0
11000004
1
11000004
2
11000004
3
11000004
8
11000004
9
11000005
0
11000005
1
11000005
2
15%)
0&+
0&+&
-FP (A-fetoprotein)
Hb-H
A
(Hadisty Test)
(AGGREGATION)
+E
-
*3'
0&9
33230
( )
G6PD)
11000005
3
11000005
6
11000005
7
11000005
8
11000006
0
11000006
1
11000006
2
11000006
3
11000006
4
11000006
5
11000006
6
11000006
7
11000007
0
11000007
1
11000007
2
11000007
3
11000007
4
11000007
5
11000007
6
11000007
7
11000007
8
11000007
9
11000008
+HLQ]
%HWNH
Thrombofax -
(APTT)
Pacie)
5KHVXV
5KHVXV
^
+XKQHU7HVW
Sia Test
33231
( )
$3
11000008
1
11000008
2
11000008
3
3$6
11000008
4
11000008
5
11000008
6
11000008
9
11000009
0
11000009
1
11000009
2
11000009
3
11000009
6
11000009
8
11000009
9
11000010
0
11000010
1
11000010
2
11000010
3
11000010
4
11000010
5
11000010
6
11000010
/(
TEST)
6LQJHU
5KHVXV
,,,
7HVW
7KRUQ
+&7+
&RRPEV
3/7
&RRPEV
2,23
33232
( )
11000010
8
11000010
9
11000011
0
11000011
1
11000011
3
11000011
4
11000011
5
11000011
6
11000011
7
11000011
8
11000011
9
11000012
0
11000012
1
11000012
2
11000012
3
11000012
5
11000012
6
11000012
7
11000012
8
11000012
9
11000013
0
11000013
-
TKE
--
'-DIMERS (FDP)
+2:(/
/((:+,7(
-
1&
THROMBOTEST
33233
( )
1
11000013
2
11000013
3
11000013
4
11000013
5
11000013
6
11000013
7
11000013
8
11000013
9
11000014
0
11000014
1
11000014
2
11000014
3
11000014
4
11000014
5
11000014
6
11000014
7
11000014
8
11000015
0
)H
9LU&
E
E)
-28;,63(8%5(<
+E
--AT)
2,3
- '3*
(SANDIAN BLACK) -
)
(ACITIFIED GLYCEND
LYSIS TEST - AGL-T)
9%7
*(1(
MAPPING)
33234
( )
11000025
4
11000026
7
11000026
8
11000026
9
12000000
1
12000001
2
12000001
3
12000001
4
12000001
5
12000001
6
12000001
7
12000001
8
12000001
9
12000002
9
12000003
0
12000003
9
12000004
1
12000004
3
12000004
4
&
,,,
&
-
(GALLA, LA, GIGR, TDT)
7
33'
7
-7
-
(T8)
(ANTI-+%V
$J
(ANTI - +%F
+$9
33235
( )
12000005
2
12000005
3
12000005
4
12000005
7
12000005
8
12000006
0
12000006
1
12000006
2
12000006
3
12000006
4
12000006
6
12000006
7
12000006
8
12000006
9
12000007
0
12000007
1
12000007
2
12000007
3
12000007
4
12000007
,J$
,J*
31(802
IgG ABS)
,J0
31(802
IgM ABS)
,J*
5,54
,J0
LEISMANIA DONOVANI
BRUCELLA MELITENSIS
&
-TEST)
,J0,J*,J$
-Antichymotrypsin,
&K\PRWKU\SVLQ
0%7
33236
( )
5
12000007
6
12000007
7
12000007
8
12000008
7
12000008
8
12000008
9
12000009
3
12000009
4
12000009
5
12000009
6
12000009
7
12000009
9
12000011
6
12000011
7
12000011
9
12000012
6
12000012
7
12000012
8
12000012
9
12000014
2
12000015
6
12000015
7
12000015
,J*,J$
,J0
(CEA)
6H[
Chromatine
(HBsAg)
$17,-TG)
$17,-M,
ANTI-732-TPO)
$17,-T
$60$
$0$$17,AMA)
3&$
APCA)
'1$
'1$
,J$
,J0
,J(
+/$-DR
33237
( )
12000016
0
*UDYLV
(ANTI MUSK)
(ANA)
17,-HBc-IgG
17,-HBc-IgM
+/$
(APCA)
+/$
(RAST)
$1&$
A NCA C
A NCA P
+/$
2
&+
(RAST)
C3
C4
,J*
12000016
1
12000016
7
12000018
6
12000018
7
12000019
9
12000020
0
12000020
4
12000020
5
12000020
6
12000020
7
12000020
8
12000020
9
12000021
2
12000021
3
12000021
4
12000021
5
12000021
6
12000021
7
33238
( )
12000021
9
12000022
0
12000022
1
12000022
3
12000022
8
12000022
9
12000023
0
12000023
3
12000023
5
12000026
2
12000029
2
12000029
4
12000029
5
12000034
9
12000036
9
12000038
6
12000038
7
12000038
8
12000038
9
12000039
9
12000040
2
12000041
6
&$
CA 19-
CA 72-
&$
(NSE)
SCC
36$
73$
&$-
+,9,,,
-
HLA - $%
HLA - '5
7(67
7*$%
33239
( )
12000041
7
12000041
8
12000041
9
12000042
0
12000042
1
12000042
2
12000048
8
12000048
9
12000049
0
12000049
1
12000049
2
12000049
3
12000049
4
12000049
5
12000049
6
12000049
7
12000049
8
12000049
9
12000050
0
13000000
8
13000001
6
13000001
7
(/,6$,/
(/,6$,/
(/,6$,/
(/,6$,/
(/,6$,/
(/,6$71)
SCD23
&
,*J
-
-
3%,
3+(1<172,1
9,40
33240
( )
13000001
8
13000002
1
13000002
4
13000002
5
13000002
8
13000003
1
13000003
2
13000003
3
13000003
4
13000003
5
13000003
6
13000003
7
13000003
8
13000004
0
13000004
1
13000004
2
13000004
3
13000004
4
13000004
5
13000004
6
13000004
7
13000004
8
13000004
9
(OSMOLALITY)
-
$/3
-
*/&
-&3.
ygt
C1
(2-
(2-
33241
( )
13000005
0
13000005
1
13000005
2
13000005
3
13000005
4
13000005
5
13000005
6
13000005
7
13000005
8
13000005
9
13000006
3
13000006
4
13000006
5
13000006
6
13000006
7
13000006
8
13000007
0
13000007
1
13000007
2
13000007
3
13000007
4
13000007
5
13000007
6
13000007
7
)H
3%&
3UHJQRVWLFXP&RQDYLV
Test
*DOOL
0DQLQL7HVW
6*37-SGOT)
/,
5-
(5-NT)
+6
%HQVH-RQHV
33242
( )
13000007
8
13000007
9
13000008
0
13000008
1
13000008
2
13000008
3
13000008
4
13000008
5
13000008
6
13000008
7
13000008
8
13000009
0
13000009
1
13000009
2
13000009
4
13000009
5
13000009
6
13000009
7
13000009
8
13000009
9
13000010
0
13000010
2
13000010
3
13000010
--
HIAA)
'-xylose
&OHDUDQFH
&OHDUDQFH
/'+
7HWUDVRUEH
Coipon
- &/
%,/
&5
5+
33243
( )
13000010
6
13000011
0
13000011
1
13000011
2
13000011
3
13000011
4
13000011
5
13000011
6
13000011
7
13000011
8
13000012
1
13000012
3
13000012
4
13000012
8
13000012
9
13000013
0
13000013
1
1D
.
3
--
-
4,04
-HT)
a-D-
A
7DFDWD$UD
Bromsulfophthalein (BSP -Sulfo-Phthalein),
33244
( )
13000013
2
13000013
3
13000013
4
13000013
6
13000013
7
13000013
8
13000013
9
13000014
0
13000014
1
13000014
2
13000014
3
13000014
4
13000014
5
13000014
6
13000014
7
13000014
9
13000015
2
13000015
3
13000015
4
13000015
7
13000015
8
13000015
$
(APO-A1)
%$32B)
'13+
(PAULY TEST)
-
--
+E$&
-
-ALA)
',*2;,1
'HSDNLQH
+'/CHOLESTEROL)
/'/CHOLESTEROL)
CPK)
/'+
&$03
6,37
33245
( )
13000016
0
13000016
1
13000016
2
13000016
3
13000016
4
13000016
5
13000016
7
13000016
8
13000016
9
13000017
0
13000017
1
13000017
2
13000017
3
13000017
4
13000017
5
13000017
6
13000017
7
13000017
8
13000017
9
13000018
0
13000018
1
13000018
2
13000018
&$03
&$03
(LDH)
$/*,$1%/8(
0%&.-MB)
3$1$*(/
(TLC)
(TLC)
2+-PR)
-6
33246
( )
13000018
4
13000018
5
13000018
6
13000018
7
13000018
8
13000018
9
13000019
1
13000019
2
13000019
3
13000019
4
7HJUHWRO
13000019
5
13000019
6
13000019
7
13000019
8
13000020
6
13000020
9
13000027
0
13000028
4
13000028
5
13000028
6
16000000
)H
+'/-C, LDL-C,
VLDL-&
-
(Pb)
>/3A@
&53
$,
/3$,
(1<
+3/&(1<
33247
( )
3
%*3
16000000
4
16000000
7
(ALDO )
(ALDO )
)6+
/+
76+
76+$17,-76+
76,$EV
76+76,
76+UHFHSWRUDXWR$E
(TSI ABS)
76+
75+75+WHVW76+
76+
75+75+WHVW76+
)6+
75+WHVW)6+
(FSH)
75+WHVW)6+
/+75+
WHVW/+
/+75+
WHVW/+
58
(T3)
16000000
8
16000001
2
16000001
3
16000001
4
16000001
5
16000001
6
16000001
7
16000001
8
16000002
0
16000002
1
16000002
2
16000002
3
16000002
4
16000002
5
16000002
33248
( )
6
)7
16000002
7
16000002
9
16000003
0
16000003
1
)7
67+*+
*+
(GH) 75+WHVW*+
90', 120')
(TESTO)
)
37+LQWDFW
(PRG)
35/
11,02
-
-HCG)
75+WHVW/+
90', 120')
75+WHVW)6+
60', 90', 120')
90$
16000003
4
16000003
5
16000003
7
16000003
9
16000004
0
16000004
2
16000004
3
16000004
4
16000004
5
16000004
6
16000004
8
16000004
9
16000005
1
16000005
2
16000005
3
33249
( )
16000005
4
16000005
5
16000005
6
16000005
7
16000005
8
16000005
9
16000006
0
16000006
1
16000006
3
16000006
4
16000006
5
16000006
7
16000006
9
16000007
0
16000007
1
16000007
3
16000007
5
16000007
6
16000008
0
16000008
1
16000008
2
16000008
$&7+
(
+3/
0
+3/
-
0
+3/
- 7HVW
(PRA)
+2
(RT3)
B-
GLUCAGON
C-&PEPTIDE)
'+($
'+($-S)
/+
- RH
/+
- 5+
6+%*
33250
( )
3
16000008
4
16000008
5
16000008
6
16000008
7
16000008
8
16000008
9
16000009
0
16000009
1
16000009
2
16000009
3
16000009
7
16000012
6
16000012
7
16000012
8
7%*
7*
,QVXOLQ
&7
TRH
*15+
17-
-OHPRG)
-'
2+'
(
.
, 21 2015
33252
( )
:
... 1 16 1 0,20 .
... 0,15 .
DVD/CD:
150
40
15
...
110
30
300
80
30
...
100
50
...
...
200
20
.....
100
....
50
110
30
...
2.250
225
160
.....
320
...
160
...
225
65
...
65
....
70
....
65
...
10
...
.... ( ) , 70 ,
.
(...). ( . . 9067/28.2.2005
2 ) ,
( 34, .. 104 32 ).
, ,
.
, ,
, , ....,
(50%) .
.... (5% ), (... 3512)
.
.... .
(www.et.gr)
H : http://www.et.gr email: webmaster.et@et.gr
08:00 13:30
*02028162212150028*